In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates

The in vitro activity of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, was tested against 2,440 clinical isolates. Nemonoxacin was at least fourfold more active than levofloxacin and moxifloxacin against most gram-positive cocci tested (shown by the following MIC(90)/range [μg/ml] value...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Adam, Heather J., Laing, Nancy M., King, C. Richard, Lulashnyk, Ben, Hoban, Daryl J., Zhanel, George G.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 2009
Témata:
Susceptibility
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2772340/
https://ncbi.nlm.nih.gov/pubmed/19738018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00078-09
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky